Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Cell Death and Differentiation|November 24, 2023
Exploring the genetic and molecular basis of differences in multiple myeloma of individuals of African and European descentArnold J Levine, John D Carpten, Maureen Murphy, et al.
Plos One|May 24, 2011
EphB2 SNPs and sporadic prostate cancer risk in African American menChristiane M Robbins, Stanley Hooker, Rick A Kittles, et al.
Scientific Reports|February 8, 2019
Comparison of TCGA and GENIE genomic datasets for the detection of clinically actionable alterations in breast cancerPushpinder Kaur, Tania B Porras, Alexander Ring, et al.
Oncoimmunology|December 8, 2018
Profiling targetable immune checkpoints in osteosarcomaTroy A McEachron, Timothy J Triche, Laurie Sorenson, et al.
Molecular Cell|April 7, 2021
Applicability of spatial transcriptional profiling to cancer researchRania Bassiouni, Lee D Gibbs, David W Craig, et al.
Haematologica|May 30, 2013
Hypodiploid multiple myeloma is characterized by more aggressive molecular markers than non-hyperdiploid multiple myelomaScott Van Wier, Esteban Braggio, Angela Baker, et al.
World Journal of Surgery|March 18, 2014
Whole-genome sequencing of an aggressive BRAF wild-type papillary thyroid cancer identified EML4-ALK translocation as a therapeutic targetMichael J Demeure, Meraj Aziz, Richard Rosenberg, et al.
Nature Reviews. Genetics|March 22, 2016
Translating RNA sequencing into clinical diagnostics: opportunities and challengesSara A Byron, Kendall R Van Keuren-Jensen, David M Engelthaler, et al.
British Journal of Haematology|December 7, 2007
PI3K/AKT pathway activation in acute myeloid leukaemias is not associated with AKT1 pleckstrin homology domain mutationRaoul Tibes, Steven M Kornblau, Yihua Qiu, et al.
BMC Genomics|May 7, 2013
Identification of somatic mutations in cancer through Bayesian-based analysis of sequenced genome pairsAlexis Christoforides, John D Carpten, Glen J Weiss, et al.
Pageof 12